Dezima Pharma
Germany
unknown
unknown
Stage
1
Investors
About
Dezima Pharma develops novel therapies to treat metabolic and rare diseases by targeting RNA, aiming to address underlying genetic causes.
Explore Dezima Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.